Key result
The c.2997G>T dysferlin mutation was associated with late onset, proximal dominant forms of dysferlinopathy, upper limb weakness onset, and lower serum creatine kinase levels in LGMD2B patients.
Observational (n=40)
In Japanese patients with LGMD2B, the prevalent c.2997G>T mutation is associated with a late-onset, proximal-dominant phenotype with preserved cardiac function but declining respiratory function.
Answers are grounded in this paper and cite their sources.
May inform counseling on late-onset LGMD2B phenotypes in Japanese patients; extends genotype-phenotype data but leaves management unchanged.
OBJECTIVE AND METHODS: Dysferlin encoded by DYSF deficiency leads to two main phenotypes, limb girdle muscular dystrophy (LGMD) 2B and Miyoshi myopathy. To reveal in detail the mutational and clinical features of LGMD2B in Japan, we observed 40 Japanese patients in 36 families with LGMD2B in whom dysferlin mutations were confirmed. RESULTS AND CONCLUSIONS: Three mutations (c.1566C>G, c.2997G>T and c.4497delT) were relatively more prevalent. The c.2997G>T mutation was associated with late onset, proximal dominant forms of dysferlinopathy, a high probability that muscle weakness started in an upper limb and lower serum creatine kinase (CK) levels. The clinical features of LGMD2B are as follows: (1) onset in the late teens or early adulthood, except patients homozygous for the c.2997G>T mutation; (2) lower limb weakness at onset; (3) distal change of lower limbs on muscle CT at an early stage; (4) impairment of lumbar erector spinal muscles on muscle CT at an early stage; (5) predominant involvement of proximal upper limbs; (6) preservation of function of the hands at late stage; (7) preservation of strength in neck muscles at late stage; (8) lack of facial weakness or dysphagia; (9) avoidance of scoliosis; (10) hyper-Ckaemia; (11) preservation of cardiac function; and (12) a tendency for respiratory function to decline with disease duration. It is important that the late onset phenotype is found with prevalent mutations.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2012) conducted an observational in Limb girdle muscular dystrophy 2B (n=40). Dysferlin mutations (c.2997G>T) was evaluated on Clinical and mutational features. The c.2997G>T dysferlin mutation was associated with late onset, proximal dominant forms of dysferlinopathy, upper limb weakness onset, and lower serum creatine kinase levels in LGMD2B patients.
Synapse has enriched 10 related papers. Consider them for comparative context: